PM: decision on the application for modification of an agreed PIP
Decision date
Decision
P/0171/2016: EMA decision of 17 June 2016 on the acceptance of a modification of an agreed paediatric investigation plan for atrasentan
(hydrochloride) (EMEA-001666-PIP01-14-M01)